VAD‐based regimens as primary treatment for multiple myeloma

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

1984 • 667 citations

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

1986 • 336 citations

High-Dose Glucocorticoid Treatment of Resistant Myeloma

1986 • 251 citations

Prognostic factors in multiple myeloma

1975 • 235 citations

Proliferation-dependent cytotoxicity of anticancer agents: a review.

1975 • 216 citations

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

1988 • 163 citations

Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

1985 • 160 citations

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.

1983 • 156 citations

High Serum Levels of Lactic Dehydrogenase Identify a High-Grade Lymphoma-like Myeloma

1989 • 142 citations

Combination therapy for multiple myeloma

1977 • 137 citations

Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement

1988 • 111 citations

Myeloma protein kinetics following chemotherapy

1982 • 94 citations

Chemotherapy for multiple myeloma

1984 • 90 citations

A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.

1972 • 52 citations

Marrow cytometry and prognosis in myeloma.

1983 • 49 citations